Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|May 27, 2021
Protein tyrosine phosphatase receptor type C (PTPRC or CD45)Maryam Ahmed Al Barashdi, Ahlam Ali, Mary Frances McMullin, et al.
Annals of Hematology|November 2, 2023
CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapyMaryam Ahmed S Al Barashdi, Ahlam Ali, Mary Frances McMullin, et al.
BMC Bioinformatics|December 23, 2017
An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mappingGayathri Thillaiyampalam, Fabio Liberante, Liam Murray, et al.
Journal of Clinical Pathology|February 4, 2019
Relevance of TP53 for CLL diagnosticsMark A Catherwood, David Gonzalez, David Donaldson, et al.
Epidemiology (Cambridge, Mass.)|April 3, 2018
Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort StudyJohn Busby, Ken Mills, Shu-Dong Zhang, et al.
Breast Cancer Research : BCR|January 21, 2018
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort studyJohn Busby, Ken Mills, Shu-Dong Zhang, et al.
Cancers|September 23, 2020
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative NeoplasmsGraeme Greenfield, Suzanne McPherson, James Smith, et al.
British Journal of Haematology|November 28, 2008
Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemiaChristopher Jenkins, Saman Hewamana, Amanda Gilkes, et al.
Pageof 5